Year |
Citation |
Score |
2010 |
LoBue AD, Lindesmith LC, Baric RS. Identification of cross-reactive norovirus CD4+ T cell epitopes. Journal of Virology. 84: 8530-8. PMID 20573810 DOI: 10.1128/Jvi.00727-10 |
0.603 |
|
2010 |
Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. Viral shape-shifting: norovirus evasion of the human immune system. Nature Reviews. Microbiology. 8: 231-41. PMID 20125087 DOI: 10.1038/Nrmicro2296 |
0.654 |
|
2009 |
LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS. Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. Journal of Virology. 83: 3212-27. PMID 19176631 DOI: 10.1128/Jvi.01650-08 |
0.612 |
|
2008 |
Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. Plos Pathogens. 4: e1000236. PMID 19079577 DOI: 10.1371/Journal.Ppat.1000236 |
0.585 |
|
2008 |
Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunological Reviews. 225: 190-211. PMID 18837783 DOI: 10.1111/J.1600-065X.2008.00680.X |
0.674 |
|
2008 |
Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW. Antibody is critical for the clearance of murine norovirus infection. Journal of Virology. 82: 6610-7. PMID 18417579 DOI: 10.1128/Jvi.00141-08 |
0.545 |
|
2008 |
Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, Baric RS. Mechanisms of GII.4 norovirus persistence in human populations. Plos Medicine. 5: e31. PMID 18271619 DOI: 10.1371/Journal.Pmed.0050031 |
0.671 |
|
2008 |
Lindesmith LC, Donaldson EF, LoBue AD, Cannon JL, Zheng D, Vinje J, Baric RS. Phylogenic Reconstruction of the GII.4 Shell Domain and P1 and P2 Subdomains Plos Medicine. DOI: 10.1371/Journal.Pmed.0050031.G003 |
0.534 |
|
2006 |
LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine. 24: 5220-34. PMID 16650512 DOI: 10.1016/J.Vaccine.2006.03.080 |
0.673 |
|
Show low-probability matches. |